Smith & Nephew (SNN) Gross Margin (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Gross Margin of 69.83% for Q4 2024, down 0.63% on a QoQ basis from 70.27% in Q4 2022.
Smith & Nephew (SNN) Gross Margin (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Gross Margin for 15 consecutive years, with 69.83% the latest figure, recorded in Q4 2024.
- Quarterly Gross Margin changed N/A year-over-year to 69.83% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 74.47% (changed N/A YoY) and the FY2025 annual result came in at 68.01%, down 163.0% from the prior year.
- Gross Margin slipped to 69.83% in Q4 2024 per SNN's latest filing, from 70.27% in the prior quarter.
- Over the last five years, Gross Margin for SNN reached as high as 70.27% in Q4 2022 and fell as low as 68.26% in Q4 2020.
- A 4-year average of 69.33% and a median of 69.41% in 2021 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2020 — Gross Margin plunged 567 bps — and 2022, when it soared 128 bps.
- Year by year, Gross Margin stood at 68.26% in 2020, then advanced by 1 bps to 68.99% in 2021, then grew by 2 bps to 70.27% in 2022, then dropped by 1 bps to 69.83% in 2024.
- According to Business Quant data, Gross Margin over the past three periods registered 69.83%, 70.27%, and 68.99% for Q4 2024, Q4 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 43.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 69.83% |
| Dec 31, 2022 | 70.27% |
| Dec 31, 2021 | 68.99% |
| Dec 31, 2020 | 68.26% |
| Dec 31, 2019 | 73.92% |
| Dec 31, 2018 | 73.24% |
| Dec 31, 2017 | 74.19% |
| Dec 31, 2016 | 72.85% |
| Dec 31, 2015 | 75.09% |
| Dec 31, 2014 | 74.95% |
| Sep 30, 2014 | 74.13% |
| Mar 31, 2014 | 75.26% |
| Dec 31, 2013 | 74.98% |
| Mar 31, 2013 | 75.06% |
| Dec 31, 2012 | 73.07% |
| Jun 30, 2012 | 76.14% |
| Mar 31, 2012 | 73.07% |
| Dec 31, 2011 | 73.30% |
| Sep 30, 2011 | 73.59% |
| Jun 30, 2011 | 73.59% |